Cerebral Palsy (CP) is the first cause of motor disability in children worldwide. ATLAS 2030 is a robotic gait exoskeleton designed to rehabilitate children with motor disability. The objective of this study is to analyse the efficacy of a training program with ATLAS 2023 in chilren with CP.
A sample of children with CP will be divided into 2 groups, the experimental group will receive 32 sesions withe the ATLAS 2030 exoskeleton, whereas the control group will continue to receive their regular conventional therapy. Assessments will be performed at the beginning and the end of the intervention, as well as after 6, 9 and 12 months of the end of the intervention for follow-up.
Study Type
OBSERVATIONAL
Enrollment
60
sessions of rehabilitation with the ATLAS 2030 exoskeleton twice per week as part of their routine rehabilitation
Hospital Universitario Gregorio Marañón
Madrid, Spain
Hospital Infantil Universitario Niño Jesús-Servicio de Rehabilitación
Madrid, Spain
Hospital Universitario Niño Jesús-Servicio de Neuro Ortopedia
Madrid, Spain
Hospital Universitario 12 de Octubre
Madrid, Spain
Gross Motor Function Measure-88 (GMFM-88)
To measure changes in gross motor function in children with cerebral palsy using the Gross Motor Functional Measure-88. The minimum value is 0 and the maximum value is 100 .When the GMFM score is lower, the skill level is lower.
Time frame: At the beginning and the end of the intervention (4 months), as well as after 6, 9 and 12 months (follow-up)
Modified Ashworth Scale (MAS)
changes in spasticity measured by the Modified Ashworth Scale (MAS). The spasticity of each muscle group is measured with a scale scored from 0 to 4, where 0 means no spasticity and 4 means the joint is fixed and therefore, the highest level of spasticity
Time frame: Through study completion, along 1 year
Pediatric Quality of Life Inventory (PedsQLTM)
Changes in self perceived quality of life measured by the Pediatric Quality of Life Inventory (PedsQLTM). Every item is measured on a scale from 0 (higher quality of life) to 4 (lower quality of life)
Time frame: At the beginning and the end of the intervention (4 months), as well as after 6, 9 and 12 months (follow-up)
Changes in Gait Deviation Index (GDI)
Changes in Gait Deviation Index (GDI) measured with a tridimensional motion analysis system
Time frame: At the beginning and the end of the intervention (4 months), as well as after 6, 9 and 12 months (follow-up)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Universitario La Paz
Madrid, Spain